Migraine Drugs Market Trends

Migraine Drugs Market Trends

• Migraine is a common neurological condition that affects a substantial portion of the population, leading to a greater need for therapeutic options. The global rise in the number of people suffering from migraines significantly drives the demand for effective treatments, that is anticipated to propel the growth of the market.
   
• For instance, as per the American Migraine Foundation, it has been estimated that at least 39 million Americans live with migraine. This rising number of reported migraine cases, coupled with increased awareness of the disease's fatal nature has led to a growing demand for effective drug therapies, thereby driving market growth.
   
• Moreover, innovations in drug discovery and development, including new classes of migraine medications such as CGRP (calcitonin gene-related peptide) inhibitors, have provided more effective treatment options, attracting both patients and healthcare providers, further boosting the market for migraine drugs.